TG Therapeutics, Inc.

TGTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$179,894$92,933$102,304$298,887
Short-Term Investments$131,106$124,575$59,374$15,876
Receivables$129,185$51,093$0$1,389
Inventory$110,458$39,823$0$0
Other Curr. Assets$15,716$9,519$6,596$14,813
Total Curr. Assets$566,359$317,943$168,274$330,965
Property Plant & Equip (Net)$7,151$8,050$10,822$11,068
Goodwill$0$799$799$799
Intangibles$0$0$0$0
Long-Term Investments$808$0$12,404$35,533
Tax Assets$0$0$0$0
Other NC Assets$3,372$2,795$1,273$1,264
Total NC Assets$11,331$11,644$25,298$48,664
Other Assets$0$0$0$0
Total Assets$577,690$329,587$193,572$379,629
Liabilities
Payables$0$0$0$0
Short-Term Debt$1,157$1,446$1,581$2,412
Tax Payable$0$0$0$0
Deferred Revenue$11,414$152$0$0
Other Curr. Liab.$78,108$52,122$51,620$62,972
Total Curr. Liab.$90,679$53,720$53,201$65,384
LT Debt$252,562$109,349$81,479$76,635
Deferred Rev, NC$12,085$6,016$305$457
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$264,647$115,365$81,784$77,092
Other Liabilities$0$0$0$0
Cap. Leases$9,290$10,677$11,925$11,284
Total Liabilities$355,326$169,085$134,985$142,476
Equity
Pref Stock$0$0$0$0
Common Stock$156$151$146$143
Retained Earnings-$1,529,194-$1,552,577-$1,527,033-$1,328,698
AOCI$0$0$0$0
Other Equity$1,751,402$1,712,928$1,585,474$1,565,708
Total Equity$222,364$160,502$58,587$237,153
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$577,690$329,587$193,572$379,629
Net Debt$73,825$17,862-$19,244-$219,840
TG Therapeutics, Inc. (TGTX) Financial Statements & Key Stats | AlphaPilot